Sava
sava.health
Actively hiring
Biosensors
Diabetes Devices
Health & Medical Electronics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$27M
2 rounds on record
Latest round
$19M
Series A · Jul 2025 · 14 mo ago
Team
51-200
employees, estimated range
Backers
4
SOSV, Balderton Capital
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 11
New executive Sava Appoints Former Dexcom EMEA Executive as Chief Commercial Officer · sava.health
Jul 31, 2025
Raised a round Series A $19M
Jul 9, 2024
Raised a round Seed $8M · led by Balde · Pulse 2.0
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Jul 2025 | $19M | — | sava.health |
| Seed | Jul 2024 | $8M | Balde lead | Pulse 2.0 |
Registers and programsofficial lists and records that name the company
| Legal entity | SAVA Technologies Ltd. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV 
Balderton Capital 
JamJar Investments 
Norrsken Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Non-Invasive Quantum Systems. NIQS is redefining personal health through cutting-edge, needle-free glucose tracking; effortless…
Chip Technology for Wearables Sencure is an innovative start-up developing chip technology for medical devices and health-tracking…
VitalTrace develops advanced biosensor technology to support safer childbirth. Our real-time fetal monitoring system helps detect distress…
Epicore Biosystems' wearable hydration biosensors track sweat biomarkers in real time to prevent heat stress and optimize health and safety.
Nix is the first biosensor to provide endurance athletes with personalized hydration intelligence — grounded in science, backed by data…
Discover how Shen AI turns your smartphone into a health companion - no wearables, just powerful, camera-based health insights.
News
Report
Report
Sava Appoints Former Dexcom EMEA Executive as Chief Commercial Officer
Global business executive John Bernard appointed as Chief Commercial Officer to lead Sava's commercial scale-up Sava advances expansion discussions, targeting structured European distribution agreements and wider international engagement London, 00.00am,
Read more
Report
Report
Sava reports world-first 10-day clinical evidence for continuous glucose monitoring via proprietary microsensor technology
Full cohort results show glucose can be accessed and measured in interstitial fluid using Sava's proprietary microsensor technology over a 10-day period Milestone validates the clinical foundation for Sava's pioneering biosensing platform, which performs
Read more
Report
How hard can it be to build a CGM?!
At first glance, it doesn't add up. Continuous Glucose Monitors (CGMs) tackle an urgent, global crisis. With over 800 million people...
Read more
Report
CGMs Are Just Getting Started - What Comes Next?
Think about the systems we rely on every day - the ones we can't afford to fail. We track them, measure them, and monitor them...
Read more
Report
Sava raises $19M Series A amid world-first clinical results for next-gen biosensor
Sava has developed the world's first multi-molecule biosensor capable of detecting biomarkers just under the skin in real-time, enabled by its proprietary microsensing technology. Its first product - a pain-free, affordable, and accurate Continuous Glucos
Read more
Report
In Conversation with Balderton: Reinventing Health Monitoring with SAVA
What if real-time health monitoring didn't require bulky devices, invasive tests, or sky-high costs? At SAVA, that's not a distant dream...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ
50-200 est. staff